Clinical trial
Carmustine in Treating Adults With Recurrent Supratentorial Low-Grade Glioma
NCT00003467 · Duke University, Other · Completed
Key facts
| NCT number | NCT00003467 |
|---|---|
| Title | Carmustine in Treating Adults With Recurrent Supratentorial Low-Grade Glioma |
| Official title | Phase II Treatment of Adults With Recurrent Supratentorial Low Grade Glioma With Gliadel Wafers |
| Lead sponsor | Duke University, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors |
| Intervention type | Drug, Procedure |
| Interventions | carmustine, polifeprosan 20 with carmustine implant, surgical procedure |
| Enrollment | 68 |
| Start date | Jan 1, 1998 |
| Completion | Feb 1, 2004 |
| First posted | Jan 27, 2003 |
| Last update posted | Jun 20, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: